Immucell (ICCC) Change in Inventory (2010 - 2025)
Immucell's (ICCC) quarterly Change in Inventory came in at -$534636.0 in Q4 2025, down 53.71% YoY from -$1.2 million in Q4 2024, and down 135.46% on a QoQ basis from $1.5 million in Q3 2025.
Immucell (ICCC) Change in Inventory (2010 - 2025) Analysis & Trends
Immucell (ICCC) has 16 years of Change in Inventory data on file, last reported at -$534636.0 in Q4 2025.
- Quarterly Change in Inventory fell 53.71% year-over-year to -$534636.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 408.17% YoY) and the FY2025 annual result came in at $2.2 million, up 408.17% from the prior year.
- Change in Inventory retreated to -$534636.0 in Q4 2025, from $1.5 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.5 million in Q3 2025 to a low of -$662278.0 in Q1 2024.
- A 5-year average of $358742.8 and a median of $294100.0 in 2021 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2021 — Change in Inventory jumped 24826.58% — and 2024, when it plunged 328.54%.
- Tracing ICCC's Change in Inventory over 5 years: stood at $423004.0 in 2021, then jumped by 70.39% to $720756.0 in 2022, then tumbled by 40.87% to $426178.0 in 2023, then tumbled by 181.62% to -$347829.0 in 2024, then slumped by 53.71% to -$534636.0 in 2025.
- The last three Change in Inventory figures came in at -$534636.0 (Q4 2025), $1.5 million (Q3 2025), and $937060.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -534,636.00 |
| Dec 31, 2025 | -534,636.00 |
| Sep 30, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 937,060.00 |
| Jun 30, 2025 | 937,060.00 |
| Mar 31, 2025 | 244,743.00 |
| Mar 31, 2025 | 244,743.00 |
| Dec 31, 2024 | -347,829.00 |
| Dec 31, 2024 | -347,829.00 |
| Sep 30, 2024 | 160,846.00 |
| Sep 30, 2024 | 160,846.00 |
| Jun 30, 2024 | 150,043.00 |
| Jun 30, 2024 | 150,043.00 |
| Mar 31, 2024 | -662,278.00 |
| Mar 31, 2024 | -662,278.00 |
| Dec 31, 2023 | 426,178.00 |
| Dec 31, 2023 | 426,178.00 |
| Sep 30, 2023 | -150,318.00 |
| Sep 30, 2023 | -150,318.00 |